Invesco Dynamic Biotechnology & Genome ETF (PBE)
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
$326.28M
Jun 23, 2005
19.01
$3.77
ETF Constituents (23)
Illumina, Inc.
ILMN
5.734%
Alnylam Pharmaceuticals, Inc.
ALNY
4.946%
Amgen Inc.
AMGN
4.876%
Biogen Inc.
BIIB
4.192%
Neurocrine Biosciences, Inc.
NBIX
4.13%
Exelixis, Inc.
EXEL
3.801%
BioMarin Pharmaceutical Inc.
BMRN
3.635%
MannKind Corporation
MNKD
3.626%
Regeneron Pharmaceuticals, Inc.
REGN
3.404%
Incyte Corporation
INCY
3.357%
ACADIA Pharmaceuticals Inc.
ACAD
3.135%
Catalyst Pharmaceuticals, Inc.
CPRX
3.096%
Natera, Inc.
NTRA
3.01%
Protagonist Therapeutics, Inc.
PTGX
2.973%
Blueprint Medicines Corporation
BPMC
2.897%
BioCryst Pharmaceuticals, Inc.
BCRX
2.689%
Halozyme Therapeutics, Inc.
HALO
2.612%
Repligen Corporation
RGEN
2.582%
OPKO Health, Inc.
OPK
2.571%
Collegium Pharmaceutical, Inc.
COLL
2.301%
Novavax, Inc.
NVAX
2.184%
CareDx, Inc
CDNA
1.983%
Myriad Genetics, Inc.
MYGN
1.701%
ETF Constituents (23)
Illumina, Inc.
ILMN
5.734%
Alnylam Pharmaceuticals, Inc.
ALNY
4.946%
Amgen Inc.
AMGN
4.876%
Biogen Inc.
BIIB
4.192%
Neurocrine Biosciences, Inc.
NBIX
4.13%
Exelixis, Inc.
EXEL
3.801%
BioMarin Pharmaceutical Inc.
BMRN
3.635%
MannKind Corporation
MNKD
3.626%
Regeneron Pharmaceuticals, Inc.
REGN
3.404%
Incyte Corporation
INCY
3.357%
ACADIA Pharmaceuticals Inc.
ACAD
3.135%
Catalyst Pharmaceuticals, Inc.
CPRX
3.096%
Natera, Inc.
NTRA
3.01%
Protagonist Therapeutics, Inc.
PTGX
2.973%
Blueprint Medicines Corporation
BPMC
2.897%
BioCryst Pharmaceuticals, Inc.
BCRX
2.689%
Halozyme Therapeutics, Inc.
HALO
2.612%
Repligen Corporation
RGEN
2.582%
OPKO Health, Inc.
OPK
2.571%
Collegium Pharmaceutical, Inc.
COLL
2.301%
Novavax, Inc.
NVAX
2.184%
CareDx, Inc
CDNA
1.983%
Myriad Genetics, Inc.
MYGN
1.701%